Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of YJ001 spray for painful diabetic peripheral neuropathy
CTR20262125Phase 3Active
- Sponsor
- Yuejia Pharmaceutical
- Start
- Aug 2026
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of YJ001 in diabetic polyneuropathy (DPN), sponsored by Yuejia Pharmaceutical. Started Aug 2026; status: active.
02
Drugs
YJ001
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20262125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262125.